32P-post-labelling analysis of DNA adducts formed by antitumor 1-nitro-9-aminoacridines with DNA of HeLa S3 cells
- 1 December 1987
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 36 (23) , 4169-4171
- https://doi.org/10.1016/0006-2952(87)90577-6
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- DNA damage in HeLa S3 cells by an antitumor drug ledakrin and other antitumor 1-nitro-9-aminoacridinesChemico-Biological Interactions, 1984
- 32P-Postlabeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agentsCarcinogenesis: Integrative Cancer Research, 1984
- The mode of action of cytotoxic and antitumor 1-nitroacridines. II. In vivo enzyme-mediated covalent binding of a 1-nitroacridine derivative, ledakrin or nitracrine, with DNA and other macromolecules of mammalian or bacterial cellsChemico-Biological Interactions, 1983
- The mode of action of cytotoxic and antitumor 1-nitroacridines. I. The 1-nitroacridines do not exert their cytotoxic effects by physicochemical binding with DNAChemico-Biological Interactions, 1983
- 32P-postlabeling analysis of non-radioactive aromatic carcinogen — DNA adductsCarcinogenesis: Integrative Cancer Research, 1982
- In vitro binding of metabolically activated [14C]-Ledakrin, or 1-nitro-9-14C-(3′-dimethylamino-n-propylamino) acridine, a new antitumor and DNA cross-linking agent, to macromolecules of subcellular fractions isolated from rat liver and HeLa cellsBiochemical Pharmacology, 1979